SEC Filing Analysis: HERON THERAPEUTICS, INC. /DE/ (HRTX)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A senior executive at Heron Therapeutics acquired shares through the routine vesting of Restricted Stock Units (RSUs), a standard component of executive compensation.
• Market Impact: Minimal. The transaction is too small to have a material impact on the stock price or trading volume.

Company Information

Field	Value
Company	HERON THERAPEUTICS, INC. /DE/
Ticker Symbol	HRTX
CIK	0000818033
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	Forbes William P
CIK	0001314760
Title/Position	EVP, Chief Development Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-31
Transaction Code	M - Exercise or conversion of derivative security
Security Type	Common Stock
Shares Involved	11,694
Price Per Share	$0.00
Total Value	$0
Shares Owned After	166,203
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0 (Vesting)
% of Market Cap	0.0%
Shares Transacted	11,694
% of Shares Outstanding	0.006%
Post-Transaction Ownership	166,203 shares (0.091% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: This transaction is immaterial for a company with a market capitalization of $210 million.
• Ownership Concentration: The insider's total holding of 166,203 shares represents a very small fraction (0.091%) of the total shares outstanding, indicating low ownership concentration from this individual.
• Dilution Impact: The vesting of 11,694 shares results in a negligible dilution of approximately 0.006% to existing shareholders. This is a routine event that is typically priced into the stock over time.
• Transaction Significance: The transaction is classified as low significance as it represents a tiny fraction of both the company's market cap and its shares outstanding. It is a scheduled compensation event, not a discretionary market trade.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a non-market transaction representing the vesting of pre-arranged equity compensation. It does not signal a change in the insider's sentiment or outlook on the company.

Volume & Sentiment

• Expected Volume Impact: Negligible. As this was not an open-market transaction, it will not directly affect trading volume.
• Sentiment Indicator: Neutral. The market generally views scheduled RSU vestings as routine and non-indicative of new information.

Additional Context

Transaction Notes

• Special Circumstances: The transaction represents the vesting of Restricted Stock Units (RSUs) into common stock, as indicated by the 'M' code and the corresponding disposition of RSUs in the derivative table. The footnote confirms the RSUs vest in installments, making this a scheduled event.